Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock
Recruiting now
Conditions studied: Cardiogenic Shock Acute, Bypass, Cardiopulmonary, Septic Shock, Mechanical Circulatory Support, Myocardial Infarction (MI), Cardiogenic Shock Post Myocardial Infarction
In brief
Mixed cardiogenic-vasoplegic shock (M-CS) represents a distinct and severe phenotype of cardiogenic shock characterized by concomitant myocardial dysfunction and inappropriate systemic vasodilation. Despite its clinical relevance, the epidemiology, management, and outcomes of M-CS remain poorly defined. This retrospective, multicenter, observational registry aims to evaluate the clinical outcomes and prognostic factors associated with mixed cardiogenic-vasoplegic shock. The study will analyze clinical, biological, and invasive hemodynamic data routinely collected during patient management for M-CS. All included patients will have been admitted for cardiogenic shock, with or without vasoplegia, defined by low cardiac output and, when present, decreased systemic vascular resistance despite adequate filling pressures requiring vasopressor support. The primary objective is to describe mortality and organ failure rates, while secondary analyses will identify determinants of adverse outcomes and potential phenotypic subgroups. The PROMIX registry will be conducted across three French university hospitals (CHU Amiens-Picardie, CHU Dijon-Bourgogne, and CHU Rouen-Normandie). This study is non-interventional, involving only data obtained as part of routine critical care, and will provide the first multicenter overview of this complex and underrecognized form of cardiogenic shock.
Key facts
- Study ID
- NCT07354568
- Run by
- Centre Hospitalier Universitaire, Amiens
- People needed
- 2500
- Starts
- 2025-10-20
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-01-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patient (>18 years old)
- Admitted to an intensive care unit for cardiogenic shock, at least SCAI stage C
- No opposition to data use
You may not qualify if…
- Missing key data, particularly regarding vasopressor doses and outcomes.
- Pregnant women
- Non-eligible shock etiologies, including but not limited to:
- Anaphylactic shock,
- Isolated hemorrhagic shock,
- Severe burns or major trauma,
- Severe acute pancreatitis,
- Fulminant hepatic failure,
- Neurogenic shock.
- Adult under legal protection (guardianship, curatorship, or judicial protection).
Where it is running
- CHU Amiens Picardie — Amiens, Somme, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.